We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00414648
Recruitment Status : Unknown
Verified August 2009 by Office of Rare Diseases (ORD).
Recruitment status was:  Active, not recruiting
First Posted : December 21, 2006
Last Update Posted : August 28, 2009
Sponsor:
Collaborator:
FDA Office of Orphan Products Development
Information provided by:
Office of Rare Diseases (ORD)